China SXT Pharmaceuticals, Inc. Research and Development Expense
China SXT Pharmaceuticals, Inc. (SXTC) reported Research and Development Expense of $184.19 thousand for the 12-month period ending 2024-03-31, per its 20-F filed 2024-08-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2024-08-13
| Period end | Research and Development Expense 12 month |
|---|---|
| 2024-03-31 | $184.19K 20-F · filed 2024-08-13 |
| 2023-03-31 | $200.72K 20-F · filed 2024-08-13 |
| 2022-03-31 | $367.00K 20-F · filed 2024-08-13 |